CLAY B SIEGALL Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CLAY B SIEGALL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CLAY B SIEGALL. CLAY B SIEGALL is President & CEO in SEATTLE GENETICS INC /WA ($SGEN) and President and CEO in SEATTLE GENETICS INC /WA ($SGEN) and See Remarks in SEATTLE GENETICS INC /WA ($SGEN) and Director in ALDER BIOPHARMACEUTICALS INC ($ALDR) and in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Mirna Therapeutics, Inc. ($MIRN).
Latest Insider Trading Transactions of CLAY B SIEGALL
Sentiment: All, ALDR, SGEN, SYBX, RARE
Page: < prev 1 2 3 4 5 6 7 8 ... 9 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 1,593 | 19,371 | 750,762 | 749.2 K to 750.8 K (+0.21 %) |
| May 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 68.35 | 13,431 | 918,009 | 749,169 | 762.6 K to 749.2 K (-1.76 %) |
| May 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 13,431 | 163,321 | 762,600 | 749.2 K to 762.6 K (+1.79 %) |
| May 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 68.91 | 300 | 20,673 | 749,169 | 749.5 K to 749.2 K (-0.04 %) |
| May 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 300 | 3,648 | 749,469 | 749.2 K to 749.5 K (+0.04 %) |
| Apr 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 2,800 | 34,048 | 80,593 | |
| Apr 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 8,541 | 103,859 | 83,393 | |
| Apr 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 8,807 | 107,093 | 91,934 | |
| Apr 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 78.00 | 2,800 | 218,400 | 749,169 | 752 K to 749.2 K (-0.37 %) |
| Apr 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 2,800 | 34,048 | 751,969 | 749.2 K to 752 K (+0.37 %) |
| Apr 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 79.05 | 8,541 | 675,166 | 749,169 | 757.7 K to 749.2 K (-1.13 %) |
| Apr 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 8,541 | 103,859 | 757,710 | 749.2 K to 757.7 K (+1.14 %) |
| Apr 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 79.77 | 8,807 | 702,534 | 749,169 | 758 K to 749.2 K (-1.16 %) |
| Apr 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 8,807 | 107,093 | 757,976 | 749.2 K to 758 K (+1.18 %) |
| Mar 20 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 8,223 | 99,992 | 0 | |
| Mar 20 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 8,333 | 99,996 | 0 | |
| Mar 20 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 8,333 | 99,996 | 749,169 | 740.8 K to 749.2 K (+1.12 %) |
| Mar 20 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 8,223 | 99,992 | 740,836 | 732.6 K to 740.8 K (+1.12 %) |
| Mar 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 7,502 | 91,224 | 100,741 | |
| Mar 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 12,646 | 153,775 | 108,243 | |
| Mar 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 68.86 | 7,502 | 516,588 | 732,613 | 740.1 K to 732.6 K (-1.01 %) |
| Mar 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 7,502 | 91,224 | 740,115 | 732.6 K to 740.1 K (+1.02 %) |
| Mar 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 69.39 | 12,646 | 877,506 | 732,613 | 745.3 K to 732.6 K (-1.70 %) |
| Mar 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 12,646 | 153,775 | 745,259 | 732.6 K to 745.3 K (+1.73 %) |
| Feb 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | See Remarks | Option Exercise | M | 12.16 | 8,077 | 98,216 | 120,889 | |
| Feb 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | See Remarks | Option Exercise | M | 12.16 | 7,100 | 86,336 | 128,966 | |
| Feb 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | See Remarks | Option Exercise | M | 12.16 | 3,571 | 43,423 | 136,066 | |
| Feb 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | See Remarks | Option Exercise | M | 12.16 | 1,400 | 17,024 | 139,637 | |
| Feb 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | See Remarks | Sell | S | 64.49 | 8,077 | 520,886 | 732,613 | 740.7 K to 732.6 K (-1.09 %) |
| Feb 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | See Remarks | Buy | M | 12.16 | 8,077 | 98,216 | 740,690 | 732.6 K to 740.7 K (+1.10 %) |
| Feb 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | See Remarks | Sell | S | 65.00 | 7,100 | 461,500 | 732,613 | 739.7 K to 732.6 K (-0.96 %) |
| Feb 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | See Remarks | Buy | M | 12.16 | 7,100 | 86,336 | 739,713 | 732.6 K to 739.7 K (+0.97 %) |
| Feb 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | See Remarks | Sell | S | 66.32 | 3,571 | 236,829 | 732,613 | 736.2 K to 732.6 K (-0.49 %) |
| Feb 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | See Remarks | Buy | M | 12.16 | 3,571 | 43,423 | 736,184 | 732.6 K to 736.2 K (+0.49 %) |
| Feb 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | See Remarks | Sell | S | 67.08 | 1,400 | 93,912 | 732,613 | 734 K to 732.6 K (-0.19 %) |
| Feb 12 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | See Remarks | Buy | M | 12.16 | 1,400 | 17,024 | 734,013 | 732.6 K to 734 K (+0.19 %) |
| Jan 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 3,000 | 36,480 | 141,037 | |
| Jan 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 7,100 | 86,336 | 144,037 | |
| Jan 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 4,600 | 55,936 | 151,137 | |
| Jan 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 5,448 | 66,248 | 155,737 | |
| Jan 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 64.21 | 3,000 | 192,630 | 732,613 | 735.6 K to 732.6 K (-0.41 %) |
| Jan 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 3,000 | 36,480 | 735,613 | 732.6 K to 735.6 K (+0.41 %) |
| Jan 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 65.17 | 7,100 | 462,707 | 732,613 | 739.7 K to 732.6 K (-0.96 %) |
| Jan 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 7,100 | 86,336 | 739,713 | 732.6 K to 739.7 K (+0.97 %) |
| Jan 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 66.05 | 4,600 | 303,830 | 732,613 | 737.2 K to 732.6 K (-0.62 %) |
| Jan 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 4,600 | 55,936 | 737,213 | 732.6 K to 737.2 K (+0.63 %) |
| Jan 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 67.01 | 5,448 | 365,070 | 732,613 | 738.1 K to 732.6 K (-0.74 %) |
| Jan 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 5,448 | 66,248 | 738,061 | 732.6 K to 738.1 K (+0.74 %) |
| Dec 12 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 700 | 8,512 | 161,185 | |
| Dec 12 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 13,148 | 159,880 | 161,885 | |
| Dec 12 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 6,300 | 76,608 | 175,033 | |
| Dec 12 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 60.78 | 700 | 42,546 | 732,613 | 733.3 K to 732.6 K (-0.10 %) |
| Dec 12 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 700 | 8,512 | 733,313 | 732.6 K to 733.3 K (+0.10 %) |
| Dec 12 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 59.96 | 13,148 | 788,354 | 732,613 | 745.8 K to 732.6 K (-1.76 %) |
| Dec 12 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 13,148 | 159,880 | 745,761 | 732.6 K to 745.8 K (+1.79 %) |
| Dec 12 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 59.15 | 6,300 | 372,645 | 732,613 | 738.9 K to 732.6 K (-0.85 %) |
| Dec 12 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 6,300 | 76,608 | 738,913 | 732.6 K to 738.9 K (+0.86 %) |
| Nov 09 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 13,478 | 163,892 | 181,333 | |
| Nov 09 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 6,670 | 81,107 | 194,811 | |
| Nov 09 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 61.29 | 13,478 | 826,067 | 732,613 | 746.1 K to 732.6 K (-1.81 %) |
| Nov 09 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 13,478 | 163,892 | 746,091 | 732.6 K to 746.1 K (+1.84 %) |
| Nov 09 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 62.04 | 6,670 | 413,807 | 732,613 | 739.3 K to 732.6 K (-0.90 %) |
| Nov 09 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 6,670 | 81,107 | 739,283 | 732.6 K to 739.3 K (+0.91 %) |
| Oct 09 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 6,211 | 75,526 | 201,481 | |
| Oct 09 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 13,937 | 169,474 | 207,692 | |
| Oct 09 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 76.96 | 6,211 | 477,999 | 732,613 | 738.8 K to 732.6 K (-0.84 %) |
| Oct 09 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 6,211 | 75,526 | 738,824 | 732.6 K to 738.8 K (+0.85 %) |
| Oct 09 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 77.58 | 13,937 | 1,081,232 | 732,613 | 746.6 K to 732.6 K (-1.87 %) |
| Oct 09 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 13,937 | 169,474 | 746,550 | 732.6 K to 746.6 K (+1.90 %) |
| Oct 09 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 6,211 | 75,526 | 201,481 | |
| Oct 09 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 13,937 | 169,474 | 207,692 | |
| Oct 09 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 76.96 | 6,211 | 477,999 | 732,613 | 738.8 K to 732.6 K (-0.84 %) |
| Oct 09 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 6,211 | 75,526 | 738,824 | 732.6 K to 738.8 K (+0.85 %) |
| Oct 09 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 77.58 | 13,937 | 1,081,232 | 732,613 | 746.6 K to 732.6 K (-1.87 %) |
| Oct 09 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 13,937 | 169,474 | 746,550 | 732.6 K to 746.6 K (+1.90 %) |
| Sep 19 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 1,390 | 16,902 | 221,629 | |
| Sep 19 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 8,827 | 107,336 | 223,019 | |
| Sep 19 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 9,931 | 120,761 | 231,846 | |
| Sep 19 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 78.00 | 1,390 | 108,420 | 732,613 | 734 K to 732.6 K (-0.19 %) |
| Sep 19 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 1,390 | 16,902 | 734,003 | 732.6 K to 734 K (+0.19 %) |
| Sep 19 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 77.20 | 8,827 | 681,444 | 732,613 | 741.4 K to 732.6 K (-1.19 %) |
| Sep 19 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 8,827 | 107,336 | 741,440 | 732.6 K to 741.4 K (+1.20 %) |
| Sep 19 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 76.36 | 9,931 | 758,331 | 732,613 | 742.5 K to 732.6 K (-1.34 %) |
| Sep 19 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 9,931 | 120,761 | 742,544 | 732.6 K to 742.5 K (+1.36 %) |
| Sep 04 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | A | 76.86 | 226,683 | 17,422,855 | 226,683 | |
| Sep 04 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | A | 76.86 | 1,301 | 99,995 | 1,301 | |
| Sep 04 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Grant | A | 0.00 | 95,981 | 0 | 732,613 | 636.6 K to 732.6 K (+15.08 %) |
| Aug 29 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 74.23 | 25,514 | 1,893,950 | 636,632 | 662.1 K to 636.6 K (-3.85 %) |
| Aug 29 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 74.23 | 25,514 | 1,893,950 | 636,632 | 662.1 K to 636.6 K (-3.85 %) |
| Aug 23 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 74.95 | 25,000 | 1,873,750 | 662,146 | 687.1 K to 662.1 K (-3.64 %) |
| Aug 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | See Remarks | Option Exercise | M | 11.09 | 2,120 | 23,511 | 0 | |
| Aug 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | See Remarks | Option Exercise | M | 11.09 | 2,120 | 23,511 | 0 | |
| Aug 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | See Remarks | Option Exercise | M | 11.09 | 16,711 | 185,325 | 2,120 | |
| Aug 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | See Remarks | Option Exercise | M | 11.09 | 16,711 | 185,325 | 2,120 | |
| Aug 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | See Remarks | Sell | S | 73.16 | 2,120 | 155,099 | 687,146 | 689.3 K to 687.1 K (-0.31 %) |
| Aug 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | See Remarks | Sell | S | 73.16 | 2,120 | 155,099 | 687,146 | 689.3 K to 687.1 K (-0.31 %) |
| Aug 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | See Remarks | Buy | M | 11.09 | 2,120 | 23,511 | 689,266 | 687.1 K to 689.3 K (+0.31 %) |
| Aug 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | See Remarks | Buy | M | 11.09 | 2,120 | 23,511 | 689,266 | 687.1 K to 689.3 K (+0.31 %) |
| Aug 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | See Remarks | Sell | S | 72.65 | 16,711 | 1,214,054 | 687,146 | 703.9 K to 687.1 K (-2.37 %) |
| Aug 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | See Remarks | Sell | S | 72.65 | 16,711 | 1,214,054 | 687,146 | 703.9 K to 687.1 K (-2.37 %) |
| Aug 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | See Remarks | Buy | M | 11.09 | 16,711 | 185,325 | 703,857 | 687.1 K to 703.9 K (+2.43 %) |
| Aug 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | See Remarks | Buy | M | 11.09 | 16,711 | 185,325 | 703,857 | 687.1 K to 703.9 K (+2.43 %) |
| Jul 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 3,622 | 40,168 | 18,831 | |
| Jul 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 15,210 | 168,679 | 22,453 | |
| Jul 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 69.67 | 3,622 | 252,345 | 687,146 | 690.8 K to 687.1 K (-0.52 %) |
| Jul 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 3,622 | 40,168 | 690,768 | 687.1 K to 690.8 K (+0.53 %) |
| Jul 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 68.93 | 15,210 | 1,048,425 | 687,146 | 702.4 K to 687.1 K (-2.17 %) |
| Jul 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 15,210 | 168,679 | 702,356 | 687.1 K to 702.4 K (+2.21 %) |
| Jul 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 3,622 | 40,168 | 18,831 | |
| Jul 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 15,210 | 168,679 | 22,453 | |
| Jul 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 69.67 | 3,622 | 252,345 | 687,146 | 690.8 K to 687.1 K (-0.52 %) |
| Jul 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 3,622 | 40,168 | 690,768 | 687.1 K to 690.8 K (+0.53 %) |
| Jul 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 68.93 | 15,210 | 1,048,425 | 687,146 | 702.4 K to 687.1 K (-2.17 %) |
| Jul 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 15,210 | 168,679 | 702,356 | 687.1 K to 702.4 K (+2.21 %) |
| Jun 20 2018 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Option Exercise | A | 80.69 | 5,000 | 403,450 | 5,000 | |
| Jun 20 2018 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Grant | A | 0.00 | 3,000 | 0 | 6,750 | 3.8 K to 6.8 K (+80.00 %) |
| Jun 12 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 18,132 | 201,084 | 37,663 | |
| Jun 12 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 700 | 7,763 | 55,795 | |
| Jun 12 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 65.10 | 18,132 | 1,180,393 | 687,146 | 705.3 K to 687.1 K (-2.57 %) |
| Jun 12 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 18,132 | 201,084 | 705,278 | 687.1 K to 705.3 K (+2.64 %) |
| Jun 12 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 65.64 | 700 | 45,948 | 687,146 | 687.8 K to 687.1 K (-0.10 %) |
| Jun 12 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 700 | 7,763 | 687,846 | 687.1 K to 687.8 K (+0.10 %) |
| May 25 2018 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | A | 15.50 | 15,000 | 232,500 | 15,000 | |
| May 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 6,740 | 74,747 | 56,495 | |
| May 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 7,776 | 86,236 | 63,235 | |
| May 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 4,316 | 47,864 | 71,011 | |
| May 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 54.17 | 6,740 | 365,106 | 687,146 | 693.9 K to 687.1 K (-0.97 %) |
| May 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 6,740 | 74,747 | 693,886 | 687.1 K to 693.9 K (+0.98 %) |
| May 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 55.22 | 7,776 | 429,391 | 687,146 | 694.9 K to 687.1 K (-1.12 %) |
| May 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 7,776 | 86,236 | 694,922 | 687.1 K to 694.9 K (+1.13 %) |
| May 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 55.75 | 4,316 | 240,617 | 687,146 | 691.5 K to 687.1 K (-0.62 %) |
| May 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 4,316 | 47,864 | 691,462 | 687.1 K to 691.5 K (+0.63 %) |
| Apr 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 18,832 | 208,847 | 75,327 | |
| Apr 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 50.52 | 18,832 | 951,393 | 687,146 | 706 K to 687.1 K (-2.67 %) |
| Apr 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 18,832 | 208,847 | 705,978 | 687.1 K to 706 K (+2.74 %) |
| Apr 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 18,832 | 208,847 | 75,327 | |
| Apr 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 50.52 | 18,832 | 951,393 | 687,146 | 706 K to 687.1 K (-2.67 %) |
| Apr 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 18,832 | 208,847 | 705,978 | 687.1 K to 706 K (+2.74 %) |
| Mar 22 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President & CEO | Option Exercise | A | 34.20 | 37,280 | 1,274,976 | 37,280 | |
| Mar 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 14,068 | 156,014 | 94,159 | |
| Mar 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 4,764 | 52,833 | 108,227 | |
| Mar 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 57.17 | 14,068 | 804,268 | 687,146 | 701.2 K to 687.1 K (-2.01 %) |
| Mar 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 14,068 | 156,014 | 701,214 | 687.1 K to 701.2 K (+2.05 %) |
| Mar 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 57.76 | 4,764 | 275,169 | 687,146 | 691.9 K to 687.1 K (-0.69 %) |
| Mar 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 4,764 | 52,833 | 691,910 | 687.1 K to 691.9 K (+0.69 %) |
| Feb 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 10,400 | 115,336 | 112,991 | |
| Feb 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 7,632 | 84,639 | 123,391 | |
| Feb 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 800 | 8,872 | 131,023 | |
| Feb 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 49.23 | 10,400 | 511,992 | 687,146 | 697.5 K to 687.1 K (-1.49 %) |
| Feb 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 10,400 | 115,336 | 697,546 | 687.1 K to 697.5 K (+1.51 %) |